CYTOMX THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.59 USD | -0.62% |
|
-4.79% | +2.58% |
Chart calendar CytomX Therapeutics, Inc.
8abc65d8f55e898b0.MALa81ZIo-pxaVPPYtFv0wm5NrdGBu6_OVftpZpMGMc.eleWvhs88NJDXmGbG5Ujnkb7XP0uNp7JCjvdwNkUIPR7cKmbOC7o21xcJA~7d4c4a450e4480fff542a92e9c05f026
Upcoming events on CytomX Therapeutics, Inc.
Past events on CytomX Therapeutics, Inc.
| 2024-03-14 11:45 am | Barclays Global Healthcare Conference |
| 2024-03-11 05:00 pm | Q4 2023 Earnings Call |
| 2024-03-11 04:10 pm | Q4 2023 Earnings Release |
| 2024-03-05 02:50 pm | TD Cowen Health Care Conference |
| 2024-01-18 01:00 pm | B. Riley Securities Oncology Conference - Track 1 |
| 2024-01-10 08:15 pm | J.P. Morgan Healthcare Conference |
| 2023-11-29 11:30 am | Piper Sandler Healthcare Conference |
| 2023-11-16 09:00 am | Jefferies London Healthcare Conference |
| 2023-11-08 01:30 pm | BMO BioPharma Spotlight Series: Oncology |
| 2023-11-07 05:00 pm | Q3 2023 Earnings Call |
| 2023-11-07 04:15 pm | Q3 2023 Earnings Release |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1064 |
| 2023-10-18 03:30 pm | World ADC conference |
| 2023-09-26 08:10 am | Cantor Global Healthcare Conference |
| 2023-09-12 11:30 am | H.C. Wainwright Global Investment Conference |
| 2023-08-17 09:00 am | H.C. Wainwright Immune Cell Engager Conference |
| 2023-08-08 05:00 pm | Q2 2023 Earnings Call |
| 2023-08-08 04:15 pm | Q2 2023 Earnings Release |
| 2023-08-06 12:00 am | MSQ CEO Webinar |
| 2023-06-14 04:30 pm | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 57,5 67,3 -14.55% | 100 99,9 0.44% | 69,6 75,4 -7.75% | 53,2 72,1 -26.23% | 101 95,8 5.65% | 94,0 |
|
EBITDA Million USD | Released Forecast Spread | -108 -81,0 -33.63% | -46,0 -53,7 14.22% | -81,1 -83,4 2.76% | 0,00 0,00 - | 0,00 0,00 - | -64,2 |
|
EBIT Million USD | Released Forecast Spread | -111 -95,3 -16.39% | -48,6 -58,2 16.44% | -83,8 -74,9 -11.84% | -101 -85,9 -18.04% | -6,48 -9,73 33.39% | -32,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -103 -89,0 -15.33% | -46,8 -56,0 16.51% | -83,6 -73,4 -13.98% | -99,3 -84,3 -17.77% | 3,32 3,54 -6.05% | -24,5 |
|
Net income Million USD | Released Forecast Spread | -102 -89,5 -14.25% | -32,9 -42,1 21.93% | -83,6 -73,4 -13.92% | -99,3 -101 1.83% | -0,57 0,78 -172.88% | -24,5 |
|
EPS USD | Released Forecast Spread | -2,26 -1,97 -14.72% | -0,71 -0,92 22.99% | -1,30 -1,17 -11.53% | -1,51 -1,27 -19.3% | -0,01 0,01 -240.45% | -0,29 |
| Announcement Date | 27/02/20 | 24/02/21 | 01/03/22 | 27/03/23 | 11/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 19,7 25,6 -22.87% | 17,1 21,2 -19.34% | 18,2 18,4 -1.16% | 16,9 20,1 -15.65% | 0,95 18,4 -94.85% | 23,5 19,9 18.02% | 24,7 13,7 79.92% | 26,4 13,4 96.77% | 26,6 21,2 25.41% | 22,4 | 21,7 | 21,9 | 25,3 | 3,00 |
|
EBITDA Million USD | Released Forecast Spread | -23,4 -31,0 24.63% | -9,00 | -13,0 | -17,0 | -25,0 | |||||||||
|
EBIT Million USD | Released Forecast Spread | -26,3 -17,7 -48.82% | -24,0 -24,5 2.35% | -24,7 -23,1 -7.19% | -23,9 -18,2 -31.29% | -28,7 -14,8 -93.2% | -5,65 -6,52 13.3% | -3,35 -12,3 72.7% | 3,12 -12,7 124.69% | -0,61 0,16 -476.4% | -3,58 | -4,77 | -7,07 | -11,9 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,2 -16,3 -61.01% | -23,9 -24,3 1.75% | -24,2 -22,5 -7.63% | -23,3 -18,2 -27.72% | -28,0 -15,3 -82.86% | -3,31 -6,13 45.99% | -1,09 -11,6 90.66% | 5,82 -11,0 152.72% | 1,91 2,02 -5.87% | -3,06 | -4,25 | -6,52 | -10,6 | |
|
Net income Million USD | Released Forecast Spread | -26,2 -16,9 -55.42% | -23,9 -24,3 1.75% | -24,2 -23,1 -4.62% | -23,3 -19,8 -17.79% | -28,0 -15,3 -82.86% | -3,31 -6,13 45.99% | -1,09 -11,6 90.66% | 2,99 -11,0 127.13% | 0,84 1,94 -56.87% | -3,07 | -4,25 | -6,52 | -10,6 | |
|
EPS USD | Released Forecast Spread | -0,40 -0,26 -54.92% | -0,37 -0,36 -1.77% | -0,37 -0,35 -4.42% | -0,35 -0,30 -16.21% | -0,42 -0,23 -84.15% | -0,05 -0,11 52.53% | -0,02 -0,17 88.44% | 0,04 -0,17 123.97% | 0,01 0,02 -54.75% | -0,04 | -0,05 | -0,08 | -0,12 | |
| Announcement Date | 01/03/22 | 05/05/22 | 04/08/22 | 08/11/22 | 27/03/23 | 09/05/23 | 08/08/23 | 07/11/23 | 11/03/24 | - | - | - | - | - |
More events
Past sector events for CytomX Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CTMX Stock
- Calendar CytomX Therapeutics, Inc.
